> top > docs > PMC:7074432 > spans > 1780-2391 > annotations

PMC:7074432 / 1780-2391 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
96 0-13 Gene denotes Neuraminidase Gene:4758
97 97-105 Species denotes MERS-CoV Tax:1335626
98 154-162 Species denotes patients Tax:9606
99 196-204 Species denotes patients Tax:9606
100 218-233 Species denotes influenza virus Tax:11309
101 354-362 Species denotes MERS-CoV Tax:1335626
102 423-431 Species denotes MERS-CoV Tax:1335626
103 484-493 Species denotes 2019-nCoV Tax:2697049
104 60-69 Species denotes influenza Tax:11309
105 172-183 Chemical denotes oseltamivir MESH:D053139
106 266-277 Chemical denotes oseltamivir MESH:D053139
107 314-325 Chemical denotes oseltamivir MESH:D053139
108 408-419 Chemical denotes oseltamivir MESH:D053139
109 437-448 Chemical denotes Oseltamivir MESH:D053139

LitCovid-PMC-OGER-BB

Id Subject Object Predicate Lexical cue
T107 14-24 CHEBI:35222;CHEBI:35222 denotes inhibitors
T106 97-105 SP_9 denotes MERS-CoV
T105 172-183 CHEBI:7798;CHEBI:7798 denotes oseltamivir
T104 218-227 NCBITaxon:7719 denotes influenza
T103 228-233 NCBITaxon:10239 denotes virus
T102 266-277 CHEBI:7798;CHEBI:7798 denotes oseltamivir
T101 314-325 CHEBI:7798;CHEBI:7798 denotes oseltamivir
T100 354-362 SP_9 denotes MERS-CoV
T99 408-419 CHEBI:7798;CHEBI:7798 denotes oseltamivir
T98 423-431 SP_9 denotes MERS-CoV
T97 437-448 CHEBI:7798;CHEBI:7798 denotes Oseltamivir
T96 484-493 SP_7 denotes 2019-nCoV

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T13 60-69 Disease denotes influenza http://purl.obolibrary.org/obo/MONDO_0005812
T14 218-227 Disease denotes influenza http://purl.obolibrary.org/obo/MONDO_0005812

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T8 77-78 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T9 140-141 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T10 151-153 http://purl.obolibrary.org/obo/CLO_0001000 denotes 35
T11 228-233 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T12 244-246 http://purl.obolibrary.org/obo/CLO_0001407 denotes 52
T13 433-435 http://purl.obolibrary.org/obo/CLO_0053733 denotes 11

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T16 0-24 Chemical denotes Neuraminidase inhibitors http://purl.obolibrary.org/obo/CHEBI_52425
T17 14-24 Chemical denotes inhibitors http://purl.obolibrary.org/obo/CHEBI_35222
T18 172-183 Chemical denotes oseltamivir http://purl.obolibrary.org/obo/CHEBI_7798
T19 266-277 Chemical denotes oseltamivir http://purl.obolibrary.org/obo/CHEBI_7798
T20 314-325 Chemical denotes oseltamivir http://purl.obolibrary.org/obo/CHEBI_7798
T21 408-419 Chemical denotes oseltamivir http://purl.obolibrary.org/obo/CHEBI_7798
T22 437-448 Chemical denotes Oseltamivir http://purl.obolibrary.org/obo/CHEBI_7798
T23 586-591 Chemical denotes group http://purl.obolibrary.org/obo/CHEBI_24433

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T15 0-192 Sentence denotes Neuraminidase inhibitors are indicated in the management of influenza.[9] In a study on possible MERS-CoV cases in Paris from 2013 to 2016, a total of 35 patients received oseltamivir (37.6%).
T16 193-611 Sentence denotes In patients positive for influenza virus (n = 25), 52% (n = 13) received oseltamivir and it was concluded that empirical oseltamivir can be started in suspected MERS-CoV cases.[10] Many other studies also evaluated oseltamivir in MERS-CoV.[11] Oseltamivir was also used in the management of 2019-nCoV; however, definite evidence of efficacy is inconclusive because of lack of suitable control group in the studies.[12]

2_test

Id Subject Object Predicate Lexical cue
32201439-30012113-47219407 370-372 30012113 denotes 10
32201439-30882305-47219408 433-435 30882305 denotes 11
32201439-31986264-47219409 608-610 31986264 denotes 12
T19064 370-372 30012113 denotes 10
T33497 433-435 30882305 denotes 11
T42850 608-610 31986264 denotes 12